Cellyan Biotechnology Co., Ltd Net Fee Amt
Cellyan Biotechnology Co., Ltd (HKPD) had Net Fee Amt of $47.37 as of 2026-07-14, per its S-8 filed 2026-08-13.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-13
- 2026-07-14: Net Fee Amt $47.37.
- 2026-06-12: Net Fee Amt $27.62K.
| Period end | Net Fee Amt |
|---|---|
| 2026-07-14 | $47.37 S-8 · filed 2026-08-13 |
| 2026-06-12 | $27.62K F-3 · filed 2026-06-12 |